Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ONCO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 5.942M
March 31, 2026 3.716M
December 31, 2025 5.221M
September 30, 2025 0.8366M
June 30, 2025 0.2835M
March 31, 2025 1.577M
December 31, 2024 0.6465M
September 30, 2024 0.3415M
June 30, 2024 0.9305M
March 31, 2024 4.464M
December 31, 2023 4.554M
September 30, 2023 7.654M
Date Value
June 30, 2023 9.223M
March 31, 2023 21.26M
December 31, 2022 25.75M
September 30, 2022 29.14M
June 30, 2022 22.24M
March 31, 2022 18.61M
December 31, 2021 1.928M
September 30, 2021 2.742M
June 30, 2021
March 31, 2021
December 31, 2020 4.309M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Aprea Therapeutics, Inc. 41.23M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M
Savara, Inc. 173.03M